Anagram & Information om | Engelska ordet MHRA

Exempel på hur man kan använda MHRA i en mening

• It carries out some of its work through arms-length bodies (ALBs), including executive non-departmental public bodies such as NHS England and the NHS Digital, and executive agencies such as the UK Health Security Agency and the Medicines and Healthcare products Regulatory Agency (MHRA).
• The MHRA manages the Early Access to Medicines Scheme (EAMS), which was created in 2014 to allow access to medicines prior to market authorisation where there is a clear unmet medical need.
• It is regularly updated and reviewed in consultation with the Medicines and Healthcare products Regulatory Agency (MHRA), the British Medical Association (BMA), the Royal Pharmaceutical Society (RPS), the Royal College of Nursing (RCN), the Competition and Markets Authority (CMA) and the Serious Fraud Office (SFO).
• The Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM) jointly operate the Yellow Card Scheme, which was one of the first examples of a pharmacovigilance scheme, aimed at mitigating adverse drug reactions (ADRs).
• In a first step towards the regulation of e-cigarettes, the MHRA granted Marketing Authorisations (licences) for the medicinal products e-Voke 10 mg and 15 mg Electronic Inhaler (PL 40317/0001-2) on 16 November 2015.
• It is approved by numerous regulatory administrations worldwide, including the US Food and Drug Administration (FDA) (19 October 2009), the European Union's European Medicines Agency (EMA) (14 June 2010), the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) (14 June 2010) and Australia's Therapeutic Goods Administration (TGA) (30 June 2010), for use as a treatment for advanced/metastatic renal cell carcinoma and advanced soft tissue sarcomas.
• Tapentadol was approved by the US FDA in November 2008, by the TGA of Australia in December 2010 and by the MHRA of the UK in February 2011.
• It carries out some of its work through arms-length bodies (ALBs), including executive non-departmental public bodies such as NHS England and the NHS Digital, and executive agencies such as Public Health England, the Office for Health Improvement and Disparities (OHID), the UK Health Security Agency and the Medicines and Healthcare products Regulatory Agency (MHRA).
• The first UK MHRA approved medical cannabis study was approved by REC (the MHRA ethics committee) in November 2021 with the study title of "CANPAIN feasibility study: evaluating the feasibility of undertaking a pragmatic real world trial investigating CBMP in chronic pain patients" with IRAS project ID 304548 of which will be provided by LVL Health in the UK.
• Professor Sir Michael Rawlins, chair of the Medicines and Healthcare products Regulatory Agency (MHRA), the UK body that would take over from the European Medicines Agency, told the House of Lords in January 2017 that 'one of the biggest worries' he had about setting up a stand-alone regulator in post-Brexit Britain was that the UK would be 'at the back of the queue' for new drugs.
• The new regulations require that the sale of all e-liquids and e-cigarettes should be done after notifying the Medicines and Healthcare Products Regulatory Agency (MHRA) for the case of the United Kingdom (UK).
• Despite a police search of the Immuno Biotech office and a home in January 2016, Noakes had predicted in November 2016 that the MHRA investigation would come to nothing and he would "take down" the regulator; however, Guernsey police again raided the Immuno Biotech office in Lower Pollet in February 2017 and arrested a man and a woman, which Noakes said was a "smear campaign".

Förberedelsen av sidan tog: 182,75 ms.